Cholinesterase inhibitory, anti-amyloidogenic and neuroprotective effect of the medicinal plant Grewia tiliaefolia - An in vitro and in silico study (Q38727090)

From Wikidata

Jump to navigation Jump to search

scientific article published on December 2017

Language	Label	Description	Also known as
English	Cholinesterase inhibitory, anti-amyloidogenic and neuroprotective effect of the medicinal plant Grewia tiliaefolia - An in vitro and in silico study	scientific article published on December 2017

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

5 September 2017

Cholinesterase inhibitory, anti-amyloidogenic and neuroprotective effect of the medicinal plant Grewia tiliaefolia - An in vitro and in silico study (English)

1 reference

Europe PubMed Central

PubMed publication ID

5 September 2017

medicinal plant

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Dicson Sheeja Malar

1

1 reference

Europe PubMed Central

PubMed publication ID

5 September 2017

Rajamohamed Beema Shafreen

2

1 reference

Europe PubMed Central

PubMed publication ID

5 September 2017

Shunmugiah Karutha Pandian

3

1 reference

Europe PubMed Central

PubMed publication ID

5 September 2017

Kasi Pandima Devi

4

1 reference

Europe PubMed Central

PubMed publication ID

5 September 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 December 2017

1 reference

Europe PubMed Central

PubMed publication ID

5 September 2017

Pharmaceutical Biology

1 reference

Europe PubMed Central

PubMed publication ID

5 September 2017

55

1 reference

Europe PubMed Central

PubMed publication ID

5 September 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

5 September 2017

381-393

1 reference

Europe PubMed Central

PubMed publication ID

5 September 2017

copyright license

Creative Commons Attribution 4.0 International

8 December 2016

1 reference

April 2022 Public Data File from Crossref

copyright status

1 reference

April 2022 Public Data File from Crossref

Mechanism of inhibition of cholinesterases by huperzine A

1 reference

https://api.crossref.org/works/10.1080%2F13880209.2016.1241811

21 January 2018

The ferric reducing ability of plasma (FRAP) as a measure of "antioxidant power": the FRAP assay

1 reference

https://api.crossref.org/works/10.1080%2F13880209.2016.1241811

21 January 2018

Efficacy and safety of donepezil in patients with Alzheimer's disease: results of a global, multinational, clinical experience study

1 reference

https://api.crossref.org/works/10.1080%2F13880209.2016.1241811

21 January 2018

Rhinacanthus nasutus extracts prevent glutamate and amyloid-β neurotoxicity in HT-22 mouse hippocampal cells: possible active compounds include lupeol, stigmasterol and β-sitosterol

1 reference

https://api.crossref.org/works/10.1080%2F13880209.2016.1241811

21 January 2018

Lipid peroxidation and protein oxidation in Alzheimer's disease brain: potential causes and consequences involving amyloid beta-peptide-associated free radical oxidative stress

1 reference

https://api.crossref.org/works/10.1080%2F13880209.2016.1241811

21 January 2018

Abeta(31-35) and Abeta(25-35) fragments of amyloid beta-protein induce cellular death through apoptotic signals: Role of the redox state of methionine-35.

1 reference

https://api.crossref.org/works/10.1080%2F13880209.2016.1241811

21 January 2018

Acetylcholinesterase inhibitors: pharmacology and toxicology

1 reference

https://api.crossref.org/works/10.1080%2F13880209.2016.1241811

21 January 2018

Galantamine, a cholinesterase inhibitor that allosterically modulates nicotinic receptors: effects on the course of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1080%2F13880209.2016.1241811

21 January 2018

A new and rapid colorimetric determination of acetylcholinesterase activity

1 reference

https://api.crossref.org/works/10.1080%2F13880209.2016.1241811

21 January 2018

Nitric oxide and superoxide, a deadly cocktail.

1 reference

https://api.crossref.org/works/10.1080%2F13880209.2016.1241811

21 January 2018

Age-specific incidence of Alzheimer's disease in a community population

1 reference

https://api.crossref.org/works/10.1080%2F13880209.2016.1241811

21 January 2018

Human monoamine oxidase enzyme inhibition by coffee and beta-carbolines norharman and harman isolated from coffee

1 reference

https://api.crossref.org/works/10.1080%2F13880209.2016.1241811

21 January 2018

In vitro antioxidant and in vivo prophylactic effects of two gamma-lactones isolated from Grewia tiliaefolia against hepatotoxicity in carbon tetrachloride intoxicated rats

1 reference

https://api.crossref.org/works/10.1080%2F13880209.2016.1241811

21 January 2018

The efficacy of galantamine in the treatment of Alzheimer's disease: comparison of patients previously treated with acetylcholinesterase inhibitors to patients with no prior exposure

1 reference

https://api.crossref.org/works/10.1080%2F13880209.2016.1241811

21 January 2018

Docking: successes and challenges

1 reference

https://api.crossref.org/works/10.1080%2F13880209.2016.1241811

21 January 2018

Neurobiology of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1080%2F13880209.2016.1241811

21 January 2018

Amyloidosis in Alzheimer's Disease: The Toxicity of Amyloid Beta (A β ), Mechanisms of Its Accumulation and Implications of Medicinal Plants for Therapy

1 reference

https://api.crossref.org/works/10.1080%2F13880209.2016.1241811

21 January 2018

Association of a salivary acetylcholinesterase with Alzheimer's disease and response to cholinesterase inhibitors.

1 reference

https://api.crossref.org/works/10.1080%2F13880209.2016.1241811

21 January 2018

Clinical trials and late-stage drug development for Alzheimer's disease: an appraisal from 1984 to 2014

1 reference

https://api.crossref.org/works/10.1080%2F13880209.2016.1241811

21 January 2018

Structural analysis of amyloid ? peptide fragment (25-35) in different microenvironments

1 reference

https://api.crossref.org/works/10.1080%2F13880209.2016.1241811

21 January 2018

Assessment of anti-amyloidogenic activity of marine red alga G. acerosa against Alzheimer's beta-amyloid peptide 25-35.

1 reference

https://api.crossref.org/works/10.1080%2F13880209.2016.1241811

21 January 2018

Ethnic uses, pharmacological and phytochemical profile of genus Grewia

1 reference

https://api.crossref.org/works/10.1080%2F13880209.2016.1241811

21 January 2018

Ellagic acid attenuates oxidative stress on brain and sciatic nerve and improves histopathology of brain in streptozotocin-induced diabetic rats

1 reference

https://api.crossref.org/works/10.1080%2F13880209.2016.1241811

21 January 2018

Acetylcholinergic neurotransmission and the beta-amyloid cascade: implications for Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1080%2F13880209.2016.1241811

21 January 2018

Effects of vitexin on scopolamine-induced memory impairment in rats.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6130737

4 November 2018

Nitric oxide and nitroxidative stress in Alzheimer's disease.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6130737

4 November 2018

A 30-week randomized controlled trial of high-dose tacrine in patients with Alzheimer's disease. The Tacrine Study Group.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6130737

4 November 2018

Antioxidant Determinations by the Use of a Stable Free Radical

1 reference

https://api.crossref.org/works/10.1080%2F13880209.2016.1241811

21 January 2018

The reversible cholinesterase inhibitor physostigmine has channel-blocking and agonist effects on the acetylcholine receptor-ion channel complex

1 reference

https://pubmed.ncbi.nlm.nih.gov/27931177

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1080/13880209.2016.1241811

1 reference

Europe PubMed Central

PubMed publication ID

5 September 2017

PMC publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

5 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38727090&oldid=2205958849"